Online Reporter
Anesu January
Herald Correspondent
The Medicines Control Authority of Zimbabwe (MCAZ) and the Zambia Medicines Regulatory Authority (ZAMRA) have signed a memorandum of understanding (MoU) aimed at tightening cross-border cooperation in the regulation of medical products.
In a joint statement this morning, the two parties said the five-year partnership will help in finding solutions to pharmaceutical problems.
“The detection of substandard and falsified medicines, track-and-trace systems, nanotechnology and biotechnology for medicines, vaccine and Active Pharmaceutical Ingredient (API) production and other emerging scientific and regulatory domains,” reads the statement.
“This agreement underscores a shared commitment to advancing public health, fostering innovation and ensuring access to safe, quality and efficacious medical products for citizens of both nations.”
The partnership is set to establish a framework for technical cooperation, information sharing and mutual recognition of Good Manufacturing Practice (GMP).
MCAZ director-general Richard Rukwata said that the collaboration is a milestone in regional regulatory convergence.
“By working together ZAMRA and MCAZ will leverage each other’s expertise and resources to strengthen the fight against substandard and falsified medical products and promote public health and safety in both nations,” he said.
ZAMRA director-general Makomani Siyanga said that the partnership is a commitment to ensuring that safe, effective and quality-assured medical products.
“It represents a proactive step toward harmonisation, efficiency and innovation in our regulatory systems,” he said.
